Jonušaitė, I. (2024) “The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab”, Neurologijos seminarai, 27(Nr. 3 (97), pp. 127–135. doi:10.29014/NS.2023.27.97.1.